Journalists Address Opioid Settlements, Undiagnosed ADHD, and a Georgia Chemical Fire – KFF Health News

You May Be Interested In:Medical Assistance in Dying; Health Benefits of Chocolate?


KFF Health News senior correspondent Aneri Pattani discussed Ohio’s $2 billion in opioid settlement funds on WOSU Public Media’s “All Sides with Anna Staver” on Oct. 16.

  • Click here to hear Pattani on WOSU Public Media’s “All Sides with Anna Staver”
  • Read Pattani’s coverage of opioid settlements in “Payback: Tracking the Opioid Settlement Cash”

KFF Health News senior fellow and editor-at-large for public health Céline Gounder discussed new research that suggests undiagnosed attention-deficit/hyperactivity disorder may be common in U.S. adults on CBS’ “CBS Mornings” on Oct. 15.

  • Click here to watch Gounder on “CBS Mornings”

KFF Health News contributor Andy Miller discussed the health impacts of a chemical fire in Georgia on WUGA’s “The Georgia Health Report” on Oct. 11.

  • Click here to hear Miller on “The Georgia Health Report”

KFF Health News is a national newsroom that produces in-depth journalism about health issues and is one of the core operating programs at KFF—an independent source of health policy research, polling, and journalism. Learn more about KFF.

USE OUR CONTENT

This story can be republished for free (details).

share Paylaş facebook pinterest whatsapp x print

Similar Content

Women's Health Investment Reaps High Return, Report Suggests
TAVR Beats Surveillance for Asymptomatic Aortic Stenosis
How Identity Politics Became Warped in this Minnesota Race
How Identity Politics Became Warped in this Minnesota Race
Putin Issues Warning to U.S. With New Nuclear Doctrine
Putin Issues Warning to U.S. With New Nuclear Doctrine
Trump Tariffs Could Impact Imports From Mexico, Canada, China
Trump Tariffs Could Impact Imports From Mexico, Canada, China
Your Questions About Diwali, Festival of Lights, Answered
Your Questions About Diwali, Festival of Lights, Answered
Women's Health Investment Reaps High Return, Report Suggests
Roivant to Stop Lung Disease Drug Development After Trial Failure
Today's Insight | © 2024 | News